EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:EXE - CA30224T8639 - Common Stock
21.39 CAD
-0.2 (-0.93%)
Taking everything into account, EXE scores 6 out of 10 in our fundamental rating. EXE was compared to 14 industry peers in the Health Care Providers & Services industry. While EXE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EXE is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year EXE was profitable.
EXE had a positive operating cash flow in the past year.
EXE had positive earnings in each of the past 5 years.
In the past 5 years EXE always reported a positive cash flow from operatings.
1.2 Ratios
EXE has a Return On Assets of 10.41%. This is amongst the best in the industry. EXE outperforms 85.71% of its industry peers.
EXE has a Return On Equity of 55.53%. This is amongst the best in the industry. EXE outperforms 92.86% of its industry peers.
EXE has a better Return On Invested Capital (18.54%) than 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXE is above the industry average of 7.27%.
The last Return On Invested Capital (18.54%) for EXE is above the 3 year average (11.40%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROIC | 18.54% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
The Profit Margin of EXE (5.72%) is better than 85.71% of its industry peers.
In the last couple of years the Profit Margin of EXE has grown nicely.
EXE has a Operating Margin of 8.22%. This is in the better half of the industry: EXE outperforms 78.57% of its industry peers.
EXE's Operating Margin has improved in the last couple of years.
EXE's Gross Margin of 14.15% is on the low side compared to the rest of the industry. EXE is outperformed by 85.71% of its industry peers.
In the last couple of years the Gross Margin of EXE has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
EXE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EXE has more shares outstanding
EXE has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EXE has an improved debt to assets ratio.
2.2 Solvency
EXE has an Altman-Z score of 3.24. This indicates that EXE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.24, EXE belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
EXE has a debt to FCF ratio of 3.39. This is a good value and a sign of high solvency as EXE would need 3.39 years to pay back of all of its debts.
EXE's Debt to FCF ratio of 3.39 is fine compared to the rest of the industry. EXE outperforms 78.57% of its industry peers.
EXE has a Debt/Equity ratio of 1.94. This is a high value indicating a heavy dependency on external financing.
EXE has a Debt to Equity ratio of 1.94. This is in the lower half of the industry: EXE underperforms 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Altman-Z | 3.24 |
ROIC/WACC2.4
WACC7.73%
2.3 Liquidity
A Current Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.81, EXE is in line with its industry, outperforming 57.14% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
The Quick ratio of EXE (0.81) is better than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 52.52% over the past year.
The Earnings Per Share has been growing by 22.74% on average over the past years. This is a very strong growth
EXE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.59%.
Measured over the past years, EXE shows a small growth in Revenue. The Revenue has been growing by 5.31% on average per year.
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
3.2 Future
The Earnings Per Share is expected to grow by 9.75% on average over the next years. This is quite good.
The Revenue is expected to grow by 10.83% on average over the next years. This is quite good.
EPS Next Y36.92%
EPS Next 2Y22.04%
EPS Next 3Y19.7%
EPS Next 5Y9.75%
Revenue Next Year15.35%
Revenue Next 2Y25.35%
Revenue Next 3Y18.26%
Revenue Next 5Y10.83%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 20.57, the valuation of EXE can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 85.71% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of EXE to the average of the S&P500 Index (26.92), we can say EXE is valued slightly cheaper.
With a Price/Forward Earnings ratio of 18.00, EXE is valued on the expensive side.
85.71% of the companies in the same industry are more expensive than EXE, based on the Price/Forward Earnings ratio.
EXE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.57 | ||
| Fwd PE | 18 |
4.2 Price Multiples
EXE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EXE is cheaper than 78.57% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, EXE is valued a bit cheaper than 64.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.98 | ||
| EV/EBITDA | 11.85 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXE has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EXE's earnings are expected to grow with 19.70% in the coming years.
PEG (NY)0.56
PEG (5Y)0.9
EPS Next 2Y22.04%
EPS Next 3Y19.7%
5. Dividend
5.1 Amount
EXE has a Yearly Dividend Yield of 2.36%. Purely for dividend investing, there may be better candidates out there.
EXE's Dividend Yield is rather good when compared to the industry average which is at 1.18. EXE pays more dividend than 85.71% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, EXE pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
5.2 History
The dividend of EXE has a limited annual growth rate of 2.79%.
EXE has been paying a dividend for at least 10 years, so it has a reliable track record.
EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
EXE pays out 45.22% of its income as dividend. This is a bit on the high side, but may be sustainable.
EXE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP45.22%
EPS Next 2Y22.04%
EPS Next 3Y19.7%
TSX:EXE (1/7/2026, 7:00:00 PM)
21.39
-0.2 (-0.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners24.82%
Inst Owner ChangeN/A
Ins Owners0.96%
Ins Owner ChangeN/A
Market Cap1.79B
Revenue(TTM)1.59B
Net Income(TTM)91.00M
Analysts75.56
Price Target24.44 (14.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.36% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP45.22%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)28.67%
PT rev (3m)45.13%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.8%
EPS NY rev (3m)9.54%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)3.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.57 | ||
| Fwd PE | 18 | ||
| P/S | 1.13 | ||
| P/FCF | 17.98 | ||
| P/OCF | 11.73 | ||
| P/B | 10.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.85 |
EPS(TTM)1.04
EY4.86%
EPS(NY)1.19
Fwd EY5.56%
FCF(TTM)1.19
FCFY5.56%
OCF(TTM)1.82
OCFY8.52%
SpS18.97
BVpS1.96
TBVpS-0.41
PEG (NY)0.56
PEG (5Y)0.9
Graham Number6.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROCE | 24.53% | ||
| ROIC | 18.54% | ||
| ROICexc | 26.92% | ||
| ROICexgc | 58.63% | ||
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% | ||
| FCFM | 6.27% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 150.97% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | 9.89 | ||
| Cash Conversion | 92.12% | ||
| Profit Quality | 109.55% | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 3.24 |
F-Score6
WACC7.73%
ROIC/WACC2.4
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
EPS Next Y36.92%
EPS Next 2Y22.04%
EPS Next 3Y19.7%
EPS Next 5Y9.75%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
Revenue Next Year15.35%
Revenue Next 2Y25.35%
Revenue Next 3Y18.26%
Revenue Next 5Y10.83%
EBIT growth 1Y30.7%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year10.8%
EBIT Next 3Y17.11%
EBIT Next 5Y9.15%
FCF growth 1Y199.78%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y343.54%
OCF growth 3Y31.32%
OCF growth 5Y26.02%
EXTENDICARE INC / EXE.CA FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
What is the valuation status for EXE stock?
ChartMill assigns a valuation rating of 6 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.
What is the profitability of EXE stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.
Can you provide the expected EPS growth for EXE stock?
The Earnings per Share (EPS) of EXTENDICARE INC (EXE.CA) is expected to grow by 36.92% in the next year.
Is the dividend of EXTENDICARE INC sustainable?
The dividend rating of EXTENDICARE INC (EXE.CA) is 6 / 10 and the dividend payout ratio is 45.22%.